All GLP-1 class medications have boxed warnings about thyroid C-mobile tumors noticed in rodent scientific tests, while this possibility has not been confirmed in people. The Decide on cardiovascular results demo demonstrated that semaglutide actually lessened key adverse cardiovascular functions by